Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,980
  • Shares Outstanding, K 116,356
  • Annual Sales, $ 9,990 K
  • Annual Income, $ -119,760 K
  • EBIT $ -92 M
  • EBITDA $ -90 M
  • 60-Month Beta 1.83
  • Price/Sales -345.36
  • Price/Cash Flow N/A
  • Price/Book 12.09
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.82
  • Most Recent Earnings $-0.20 on 11/07/24
  • Next Earnings Date 03/05/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 217.39% ( -9.58%)
  • Historical Volatility 93.53%
  • IV Percentile 92%
  • IV Rank 59.92%
  • IV High 325.95% on 01/14/25
  • IV Low 55.08% on 06/24/24
  • Put/Call Vol Ratio 0.29
  • Today's Volume 133
  • Volume Avg (30-Day) 1,154
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 70,326
  • Open Int (30-Day) 78,715

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.21
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6016 +8.54%
on 01/13/25
1.1400 -42.72%
on 12/18/24
-0.4470 (-40.64%)
since 12/17/24
3-Month
0.6016 +8.54%
on 01/13/25
10.6237 -93.85%
on 11/11/24
-7.9770 (-92.43%)
since 10/17/24
52-Week
0.6016 +8.54%
on 01/13/25
10.6237 -93.85%
on 11/11/24
-1.7970 (-73.35%)
since 01/17/24

Most Recent Stories

More News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT

New York, New York--(Newsfile Corp. - January 2, 2025) - Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action...

APLT : 0.6530 (+5.25%)
Applied Therapeutics Appoints John H. Johnson as Executive Chairman

APLT : 0.6530 (+5.25%)
Stocks Set for Muted Open as Investors Await U.S. Jobs Data and Powell’s Remarks

December S&P 500 E-Mini futures (ESZ24) are down -0.12%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.19% this morning as investors looked ahead to remarks from Federal Reserve Chair Jerome...

DG : 68.44 (-1.18%)
FL : 20.45 (+0.74%)
NQZ24 : 20,947.98s (-0.78%)
STLAP.FP : 12.556 (+2.85%)
TSLA : 426.50 (+3.06%)
LRCX : 80.30 (+1.36%)
CHWY : 37.01 (-0.70%)
UPST : 62.96 (-2.39%)
ESZ24 : 5,840.26s (-0.49%)
DOCU : 89.60 (-1.71%)
KLAC : 757.47 (+1.37%)
ULTA : 405.01 (-2.01%)
Applied Therapeutics Stock Craters After FDA Rejects Rare Genetic Disorder Drug Candidate: Retail Mood Dented

A CRL is a communication from the FDA that the agency cannot approve a pending regulatory application before it in its present form.

IWO : 294.66 (+0.43%)
APLT : 0.6530 (+5.25%)
XBI : 87.97 (+0.09%)
Stock Index Futures Climb as Bond Yields Fall

December S&P 500 E-Mini futures (ESZ24) are up +0.31%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.38% this morning as Treasury yields fell after cash trading resumed following the Thanksgiving...

MSTR : 396.50 (+8.04%)
MARA : 19.91 (+8.80%)
CRWD : 357.00 (-1.76%)
RMBL : 4.25 (-4.71%)
AAL.LN : 2,576.917 (+4.75%)
NQZ24 : 20,947.98s (-0.78%)
HPQ : 32.51 (+0.49%)
APLT : 0.6530 (+5.25%)
URBN : 55.01 (+3.38%)
VNET : 5.60 (-0.71%)
BTBT : 3.68 (+1.38%)
ESZ24 : 5,840.26s (-0.49%)
Applied Therapeutics Receives Complete Response Letter from FDA for Govorestat New Drug Application for Classic Galactosemia

Applied Therapeutics received a Complete Response Letter from the FDA for govorestat's NDA for Classic Galactosemia.Quiver AI SummaryApplied Therapeutics, Inc. announced that the FDA has issued a Complete...

APLT : 0.6530 (+5.25%)
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

APLT : 0.6530 (+5.25%)
Applied Therapeutics Reports Third Quarter 2024 Financial Results

APLT : 0.6530 (+5.25%)
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

APLT : 0.6530 (+5.25%)
Why Applied Therapeutics Stock Is Skyrocketing Today

Investors are cheering good news from the FDA.

APLT : 0.6530 (+5.25%)

Business Summary

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.7787
2nd Resistance Point 0.7347
1st Resistance Point 0.6939
Last Price 0.6530
1st Support Level 0.6091
2nd Support Level 0.5651
3rd Support Level 0.5243

See More

52-Week High 10.6237
Fibonacci 61.8% 6.7953
Fibonacci 50% 5.6126
Fibonacci 38.2% 4.4300
Last Price 0.6530
52-Week Low 0.6016

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar